This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruiz, P.
Right arrow Articles by Casal, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruiz, P.
Right arrow Articles by Casal, M. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2000, p. 4663-4664, Vol. 38, No. 12
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Comparison of Susceptibility Testing of Mycobacterium tuberculosis Using the ESP Culture System II with That Using the BACTEC Method

P. Ruiz, F. J. Zerolo, and M. J. Casal*

Mycobacteria Reference Center, Faculty of Medicine, University of Cordoba, 14004 Cordoba, Spain

Received 5 April 2000/Returned for modification 29 May 2000/Accepted 7 October 2000


    ABSTRACT
Top
Abstract
Text
References

The ESP Culture System II was evaluated for its capacity to test the susceptibility of 389 cultures of Mycobacterium tuberculosis to streptomycin, rifampin, ethambutol, and isoniazid. Good agreement with results with the BACTEC TB 460 was found. ESP II is a reliable, rapid, and automated method for performing susceptibility testing.


    TEXT
Top
Abstract
Text
References

The reemergence of tuberculosis and the increasing number of drug-resistant strains of Mycobacterium tuberculosis pose a public health problem requiring rapid intervention (4).

To address the problems associated with current methods of susceptibility testing, such as radioactive disposal and culture contamination, new technologies need to be developed. The ESP Culture System II instrument (AccuMed International, Westlake, Ohio [formerly Difco]) is a fully automated, nonradioactive system providing noninvasive continuous monitoring of mycobacterial cultures by measuring changes in head space pressure due to gas production or consumption during microbial growth (1).

This study was performed to determine the feasibility of the ESP Culture System II as a test of the susceptibility of M. tuberculosis to rifampin, isoniazid, streptomycin, and ethambutol, in comparison with the BACTEC method.

The mycobacterial strains used in this study were reference organisms from the American Type Culture Collection (ATCC 27294, susceptible to all drugs tested; ATCC 35820, resistant to streptomycin; ATCC 35822, resistant to isoniazid; ATCC 35837, resistant to ethambutol; and ATCC 35838, resistant to rifampin) together with 389 clinical isolates of M. tuberculosis received in our Reference Center (Faculty of Medicine, Cordoba, Spain). All strains were identified by conventional methods, DNA probes and high-pressure liquid chromatography. The reference organisms were tested with each run.

For testing with the ESP Culture System II, a standardized inoculum, equivalent to a McFarland standard of 1.0, was obtained. A 1:10 dilution was prepared and used as the inoculum source for susceptibility testing.

The ESP Myco culture bottles used in the drug susceptibility testing contained 12.5 ml of enriched Middlebrook 7H9 broth with 0.2% glycerol, 0.1% casitone, and cellulose sponge disks. Middlebrook OADC enrichment (Myco growth supplement [GS]) was added to a final concentration of 10% before the media in the bottles were inoculated with each test strain.

The ESP antituberculosis antibiotics were supplied as a lyophilate. Each bottle was rehydrated with 25 ml of sterile distilled water. Preparation of the ESP bottles for testing included the addition of 1.0 ml of antibiotic solution. The final concentrations in the Myco bottles were as follows: 8.0 µg of streptomycin/ml, 1.0 µg of rifampin/ml, 8.0 µg of ethambutol/ml, and 0.1 or 0.4 µg of isoniazid/ml.

For the inoculation of organisms into the ESP Myco bottles, 0.5 ml of a 1:10 dilution from a 1.0 McFarland standard of each strain was added to each of four drug-containing culture bottles and to one drug-free control culture bottle. A 1.0-ml volume of ESP Myco GS was also added to each bottle, giving a total volume of 15 ml per bottle. The bottles were mixed by inversion several times to ensure a proper distribution of GS, antibiotics, and inoculum throughout the Myco bottle. The bottles were placed inside the instrument once a bottle connector had been attached. A subculture of the original inoculum to blood agar and Middlebrook agar was performed to verify culture purity.

The instrument was checked periodically for positive bottles. When the control bottle signaled positive, the time of detection (TD) was calculated by rounding to the nearest whole number. Drug-containing bottles were monitored for a further 3 days after the control bottle showed positive (rounded to the nearest whole number), and the TD was obtained for all four antibiotics at all the concentrations tested. The results were interpreted according to the following formula: resistant was when the TD (drug bottle) was equal to or within (±)3 days of the control TD; sensitive was when no growth occurred or when the drug bottle TD was >3 days after the control TD (M. S. Nagar, M. T. Sweeney, L. F. Strenkoski, R. A. McMillian, Abstr. 35th Intersci. Conf. Antimicrob. Agents Chemother., abstr. D35, 1995.)

Antimycobacterial susceptibility testing with the BACTEC TB 460 was performed and the results were interpreted according to NCCLS document M24-T (6). The agar proportion method was performed according to NCCLS procedures in order to distinguish strains (6).

Data analysis involved a standard two-by-two contingency table. The incubation times required to obtain results for ESP II versus BACTEC TB 460 were compared by a paired t test (2, 3, 5). The comparative results obtained for streptomycin, rifampin, ethambutol, and isoniazid are shown in Table 1.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Susceptibility test results obtained with the ESP II system and the BACTEC TB 460

With rifampin and ethambutol (each 7.5 µg/ml), similar results from ESP II and BACTEC TB testing were observed. When 2.5 µg of ethambutol/ml was used with the BACTEC method, two strains were found resistant by BACTEC TB 460 and susceptible by ESP II and the agar proportion method.

For streptomycin, susceptibility test results had a 99.7% agreement. Only one strain was found resistant by the ESP II test and susceptible by BACTEC TB 460. When tested by the agar proportion method, this strain was found to be resistant.

Agreement for the lower concentration of isoniazid tested by ESP II was 88.6%. A total of 44 strains were found susceptible by BACTEC TB 460 and resistant by ESP II. These isolates were shown to be susceptible by the agar proportion method. Sensitivity with BACTEC TB 460 and ESP II and the negative (susceptible) predictive value were 100%. Specificity was 82%, accuracy was 88.6%, and the positive (resistant) predictive value was 76.5%.

When the higher concentration of isoniazid (0.4 µg/ml) was used with ESP II, an agreement of 98.9% with BACTEC TB 460 was obtained. Two strains were found resistant by BACTEC TB 460 and susceptible by ESP II and were also found to be resistant by the agar proportion method. Another two strains were found susceptible by BACTEC TB 460 and resistant by ESP II and the agar proportion method.

The mean time (± the standard error) to obtain results with ESP II was 4.55 (± 0.26) days, with a range of 2 to 8 days. The mean time to obtain results with BACTEC TB 460 was 4.83 (± 0.83) days, with a range of 3 to 9 days. No differences were observed in these times between resistant strains and susceptible strains in either system tested.

Good agreement of the ESP Culture System II with the BACTEC TB 460 was found. The ESP system II is a reliable, rapid, and automated method for performing susceptibility testing.


    ACKNOWLEDGMENTS

Financial support was obtained from Fondo de Investigacion Sanitaria, Ministerio de Sanidad, Madrid, Spain (Proyecto Investigacion 98/0853).


    FOOTNOTES

* Corresponding author. Mailing address: Mycobacteria Reference Center, Faculty of Medicine, University of Cordoba, 14004 Cordoba, Spain. Phone: 34-957-218284. Fax: 34-957-218229. E-mail: mi3relur{at}lucano.uco.es.


    REFERENCES
Top
Abstract
Text
References

1. Bergman, J. S., and G. L. Woods. 1998. Evaluation of the ESP Culture System II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculosis drugs. J. Clin. Microbiol. 36:2940-2943[Abstract/Free Full Text].
2. Dawson-Sanders, B., and P. E. Traoo. 1994. Summarizing data in basic clinical biostatistics, p. 41-63. Appleton and Lange, Norwalk, London, England.
3. Fleiss, J. L. 1981. Statistical methods for rates and proportions, p. 217-234. John Wiley & Sons, New York, N.Y.
4. Frieden, T. R., T. Sterling, A. Pablos-Mendez, J. O. Kilburn, G. M. Cauthen, and S. W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328:521-526[Abstract/Free Full Text].
5. McNemar, Q. 1949. Psychological statistics. John Wiley & Sons, New York, N.Y.
6. National Committee for Clinical Laboratory Standards. 1995. Antimycobacterial susceptibility testing for Mycobacterium tuberculosis. Tentative standard M24-T. National Committee for Clinical Laboratory Standards, Wayne, Pa.


Journal of Clinical Microbiology, December 2000, p. 4663-4664, Vol. 38, No. 12
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Garrigo, M., Aragon, L. M., Alcaide, F., Borrell, S., Cardenosa, E., Galan, J. J., Gonzalez-Martin, J., Martin-Casabona, N., Moreno, C., Salvado, M., Coll, P. (2007). Multicenter Laboratory Evaluation of the MB/BacT Mycobacterium Detection System and the BACTEC MGIT 960 System in Comparison with the BACTEC 460TB System for Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 45: 1766-1770 [Abstract] [Full Text]  
  • Piersimoni, C., Olivieri, A., Benacchio, L., Scarparo, C. (2006). Current Perspectives on Drug Susceptibility Testing of Mycobacterium tuberculosis Complex: the Automated Nonradiometric Systems. J. Clin. Microbiol. 44: 20-28 [Full Text]  
  • Palomino, J. C. (2005). Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. Eur Respir J 26: 339-350 [Abstract] [Full Text]  
  • Scarparo, C., Ricordi, P., Ruggiero, G., Piccoli, P. (2004). Evaluation of the Fully Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to Pyrazinamide, Streptomycin, Isoniazid, Rifampin, and Ethambutol and Comparison with the Radiometric BACTEC 460TB Method. J. Clin. Microbiol. 42: 1109-1114 [Abstract] [Full Text]  
  • Tortoli, E., Benedetti, M., Fontanelli, A., Simonetti, M. T. (2002). Evaluation of Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to Four Major Antituberculous Drugs: Comparison with the Radiometric BACTEC 460TB Method and the Agar Plate Method of Proportion. J. Clin. Microbiol. 40: 607-610 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruiz, P.
Right arrow Articles by Casal, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruiz, P.
Right arrow Articles by Casal, M. J.